Vascular smooth muscle cells in the pathogenesis of vascular calcification.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 19325156)

Published in Circ Res on March 27, 2009

Authors

Keith A Hruska

Articles by these authors

Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis. J Am Soc Nephrol (2005) 2.27

The mechanism of phosphorus as a cardiovascular risk factor in CKD. J Am Soc Nephrol (2008) 1.99

Vascular calcification in chronic kidney disease. Am J Kidney Dis (2004) 1.81

Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome. J Am Soc Nephrol (2005) 1.54

Impaired micro-RNA pathways diminish osteoclast differentiation and function. J Biol Chem (2008) 1.53

Plasma Dickkopf1 (DKK1) concentrations negatively associate with atherosclerotic calcified plaque in African-Americans with type 2 diabetes. J Clin Endocrinol Metab (2012) 1.52

RGS4, a GTPase activator, improves renal function in ischemia-reperfusion injury. Kidney Int (2011) 1.51

A microRNA expression signature of osteoclastogenesis. Blood (2011) 1.49

BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure. J Am Soc Nephrol (2003) 1.45

Plasma FGF23 and Calcified Atherosclerotic Plaque in African Americans with Type 2 Diabetes Mellitus. Am J Nephrol (2015) 1.42

Akt1/Akt2 and mammalian target of rapamycin/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors. J Biol Chem (2004) 1.40

CKD accelerates development of neointimal hyperplasia in arteriovenous fistulas. J Am Soc Nephrol (2009) 1.40

Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy. J Am Soc Nephrol (2006) 1.37

Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol (2008) 1.35

Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney Int (2003) 1.29

Admixture mapping of coronary artery calcified plaque in African Americans with type 2 diabetes mellitus. Circ Cardiovasc Genet (2012) 1.22

Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model. J Am Soc Nephrol (2004) 1.10

Inhibition of cell survival signal protein kinase B/Akt by curcumin in human prostate cancer cells. J Cell Biochem (2003) 1.07

PTEN regulates RANKL- and osteopontin-stimulated signal transduction during osteoclast differentiation and cell motility. J Biol Chem (2002) 1.06

Relationships between calcified atherosclerotic plaque and bone mineral density in African Americans with type 2 diabetes. J Bone Miner Res (2011) 1.06

Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney disease. Am J Nephrol (2013) 1.03

Adenovirus mediated BMP-13 gene transfer induces chondrogenic differentiation of murine mesenchymal progenitor cells. J Bone Miner Res (2004) 1.01

Rho-dependent Rho kinase activation increases CD44 surface expression and bone resorption in osteoclasts. J Biol Chem (2003) 0.99

The BMP-7-Smad1/5/8 pathway promotes kidney repair after obstruction induced renal injury. J Urol (2011) 0.99

Bone morphogenetic protein 7 (BMP7) gene polymorphisms are associated with inverse relationships between vascular calcification and BMD: the Diabetes Heart Study. J Bone Miner Res (2009) 0.96

The urinary response to an oral oxalate load in recurrent calcium stone formers. J Urol (2003) 0.94

Bone morphogenetic protein-7 delays podocyte injury due to high glucose. Nephrol Dial Transplant (2007) 0.93

The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling. Kidney Int (2003) 0.93

Treatment of a murine model of high-turnover renal osteodystrophy by exogenous BMP-7. Kidney Int (2002) 0.93

Leupaxin is a critical adaptor protein in the adhesion zone of the osteoclast. J Bone Miner Res (2003) 0.92

Bone morphogenetic protein 7: a novel treatment for chronic renal and bone disease. Curr Opin Nephrol Hypertens (2004) 0.91

Relationships between serum adiponectin and bone density, adiposity and calcified atherosclerotic plaque in the African American-Diabetes Heart Study. J Clin Endocrinol Metab (2013) 0.88

Polyphosphoinositides-dependent regulation of the osteoclast actin cytoskeleton and bone resorption. BMC Cell Biol (2004) 0.86

Bone morphogenetic protein-7: an anti-fibrotic morphogenetic protein with therapeutic importance in renal disease. Curr Opin Nephrol Hypertens (2002) 0.85

Proprotein convertases regulate activity of prostate epithelial cell differentiation markers and are modulated in human prostate cancer cells. J Cell Biochem (2003) 0.84

Relationships between serum MCP-1 and subclinical kidney disease: African American-Diabetes Heart Study. BMC Nephrol (2012) 0.84

Down-regulation of miR-21 biogenesis by estrogen action contributes to osteoclastic apoptosis. J Cell Biochem (2013) 0.84

Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease. Pediatr Nephrol (2014) 0.82

Sclerostin is positively associated with bone mineral density in men and women and negatively associated with carotid calcified atherosclerotic plaque in men from the African American-Diabetes Heart Study. J Clin Endocrinol Metab (2013) 0.82

Expression of DGCR8-dependent microRNAs is indispensable for osteoclastic development and bone-resorbing activity. J Cell Biochem (2014) 0.81

In vivo transplantation of neonatal ovine neocartilage allografts: determining the effectiveness of tissue transglutaminase. J Knee Surg (2005) 0.81

Left ventricular mass progression despite stable blood pressure and kidney function in stage 3 chronic kidney disease. Am J Nephrol (2014) 0.81

Endogenous BMP-7 is a critical molecular determinant of the reversibility of obstruction-induced renal injuries. Am J Physiol Renal Physiol (2011) 0.81

The Kidney-Vascular-Bone Axis in the Chronic Kidney Disease-Mineral Bone Disorder. Transplantation (2016) 0.78

New discoveries in the pathogenesis of renal osteodystrophy. J Bone Miner Metab (2006) 0.75